VR
Rollason, Victoria
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban | British journal of clinical pharmacology |  | 2025 | 18 | 0 | ||
| Antiviral Use in Mild-to-Moderate SARS-CoV-2 Infections during the Omicron Wave in Geriatric Patients | Viruses |  | 2024 | 84 | 39 | ||
| Regulatory assessment of nano-enabled health products in public health interest. Position of the scientific advisory board of the French National Agency for the Safety of Medicines and Health Products | Frontiers in public health | | 2023 | 50 | 15 | ||
| Practice of CYP450 genotyping and phenotyping in children in a real-life setting | Frontiers in pharmacology | | 2023 | 56 | 48 | ||
| Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side | CPT: pharmacometrics & systems pharmacology | | 2023 | 122 | 103 | ||
| Reproductive Safety of Trazodone After Maternal Exposure in Early Pregnancy : A Comparative ENTIS Cohort Study | Journal of clinical psychopharmacology | | 2023 | 66 | 154 | ||
| Patient and public involvement in the benefit-risk assessment and decision concerning health products : position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM) | BMJ global health | | 2023 | 74 | 30 | ||
| Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study | CPT: pharmacometrics & systems pharmacology | | 2023 | 89 | 68 | ||
| Joint Analysis of Phenotypic and Genomic Diversity Sheds Light on the Evolution of Xenobiotic Metabolism in Humans | Genome biology and evolution | | 2022 | 445 | 82 | ||
| The unusual presentation of an unusual complication: Topical corticosteroids-induced binasal heteronymous hemianopia | Thérapie | | 2022 | 316 | 0 | ||
| Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting | Journal of personalized medicine | | 2022 | 188 | 165 | ||
| Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics | CPT: pharmacometrics & systems pharmacology | | 2022 | 230 | 307 | ||
| Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail | Clinical pharmacology and therapeutics | | 2021 | 175 | 96 | ||
| Tapentadol Versus Tramadol: A Narrative and Comparative Review of Their Pharmacological, Efficacy and Safety Profiles in Adult Patients | Drugs | | 2021 | 173 | 148 | ||
| Pregnancy outcome following first-trimester exposure to fingolimod: A collaborative ENTIS study | Multiple Sclerosis Journal | | 2021 | 256 | 0 | ||
| Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic Review of the Literature and Analysis of VigiBase | Journal of personalized medicine | | 2021 | 189 | 73 | ||
| CYP450 Genotype-Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting | Frontiers in pharmacology | | 2021 | 239 | 126 | ||
| Opioïdes monoaminergiques : lequel choisir ? | Revue médicale suisse | | 2021 | 142 | 109 | ||
| Influence of Inflammation on Cytochromes P450 Activity in Adults: A Systematic Review of the Literature | Frontiers in pharmacology | | 2021 | 173 | 254 | ||
| Mazzotti reaction: Ivermectin-associated polyarthritis after delayed scabies treatment. Case report and review of the literature | Thérapie | | 2021 | 1,106 | 1 | ||
| Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review | Clinical pharmacokinetics | | 2021 | 194 | 86 | ||
| Drug interactions with apixaban: A systematic review of the literature and an analysis of VigiBase, the World Health Organization database of spontaneous safety reports | Pharmacology Research and Perspectives | | 2020 | 286 | 139 | ||
| Safety of the Geneva Cocktail, a Cytochrome P450 and P-Glycoprotein Phenotyping Cocktail, in Healthy Volunteers from Three Different Geographic Origins | Drug Safety | | 2020 | 636 | 169 | ||
| Cinderella side effect: Intravenous corticosteroid-induced bradycardia | Therapie | | 2020 | 210 | 0 | ||
| Outcomes of drug exposition during pregnancy: Analysis from a teratology information service | European Journal of Obstetrics, Gynecology, and Reproductive Biology | | 2020 | 251 | 4 | ||
| Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva Cocktail | Clinical Pharmacology and Therapeutics | | 2020 | 292 | 372 | ||
| Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective Study | Journal of Personalized Medicine | | 2020 | 328 | 82 | ||
| Through the looking glass: drug safety in the light of pharmacogenomics, drug interactions and beyond | | 2019 | 272 | 5 | |||
| Importance et particularités de la pharmacovigilance en pédiatrie | Revue médicale suisse | | 2019 | 386 | 356 | ||
| Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more? | International Journal of Clinical Pharmacy | | 2019 | 301 | 258 | ||
| Cytochrome P450 1A2 activity and incidence of thyroid disease and cancer after chronic or acute exposure to dioxins | Basic & Clinical Pharmacology & Toxicology | | 2019 | 416 | 4 | ||
| Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective study | Pharmacological research | | 2017 | 630 | 159 | ||
| Surprescription des inhibiteurs de la pompe à protons | Revue médicale suisse | | 2017 | 419 | 186 | ||
| Impact d'une réconciliation médicamenteuse par un pharmacien lors de l'admission dans un service de médecine interne | Le Pharmacien Hospitalier et Clinicien | | 2017 | 260 | 192 | ||
| Severe liver injury due to a homemade flower pollen preparation in a patient with high CYP3A enzyme activity: a case report | European Journal of Clinical Pharmacology | | 2016 | 688 | 1 | ||
| Snapshot of the prescribing practice for the clopidogrel and esomeprazole coprescription and cost evaluation of the application guidelines | Pharmacology research & perspectives | | 2016 | 626 | 268 | ||
| Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ) | Cochrane database of systematic reviews | | 2016 | 616 | 4 | ||
| Providing Quality Therapeutics in Switzerland: Role of the Stakeholders and Recent Incentives for Further Improvements | Clinical therapeutics | | 2015 | 682 | 6 | ||
| P-glycoprotein: a clue to vitamin K antagonist stabilization | Pharmacogenomics | | 2015 | 659 | 0 | ||
| Topical corticosteroid-induced skin atrophy: a comprehensive review | Drug safety | | 2015 | 531 | 0 | ||
| Use of metamizole in children and the risk of agranulocytosis: Is the benefit worth the risk? | European journal of anaesthesiology | | 2015 | 539 | 4 | ||
| Prediction by pharmacogenetics of safety and efficacy of non-steroidal anti- inflammatory drugs: a review | Current drug metabolism | 2014 | 631 | 0 | |||
| Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis | The Lancet. Psychiatry | | 2014 | 504 | 0 | ||
| Impact of clinical decision support guidelines on therapeutic drug monitoring of gentamicin in newborns | Therapeutic drug monitoring | | 2014 | 748 | 3 | ||
| Snapshot of Prescribing Practice for Clopidogrel and Esomeprazole Co-Prescription and Cost Evaluation of Guidelines Application | Value in health | | 2014 | 498 | 201 | ||
| Hypokalaemia-induced rhabdomyolysis after treatment of post-Kala-azar dermal Leishmaniasis (PKDL) with high-dose AmBisome in Bangladesh-a case report | PLoS neglected tropical diseases | | 2014 | 398 | 197 | ||
| Safety signal detection: the relevance of literature review | Drug safety | | 2014 | 577 | 1,315 | ||
| Identification and weighting of the most critical "real-life" drug-drug interactions with acenocoumarol in a tertiary care hospital | European journal of clinical pharmacology | | 2013 | 835 | 587 | ||
| Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell model | Basic & clinical pharmacology & toxicology | | 2013 | 557 | 3 | ||
| Applications of CYP450 Testing in the Clinical Setting | Molecular diagnosis & therapy | | 2013 | 686 | 806 | ||
| Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatment | Pharmacogenomics | | 2013 | 653 | 0 | ||
| Antalgie médicamenteuse et grossesse | Revue médicale suisse | | 2012 | 604 | 3 | ||
| Pharmacogenetics of analgesics: toward the individualization of prescription | Pharmacogenomics | 2008 | 548 | 0 | |||
| Clinical pharmacology and rationale of analgesic combinations | European journal of anaesthesiology. Supplement | 2003 | 363 | 0 | |||
| Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist | Drugs & aging | | 2003 | 516 | 1,448 | ||
| Effet analgesique des opiaces en usage cutane: quelle est leur efficacite? | Thérapie | 2001 | 407 | 0 |
